Drug Approval | November 22, 2021
European Commission approves Roche’s Gavreto
Gavreto is the first and only precision medicine approved in the EU for first-line treatment of people with RET fusion-positive advanced NSCLC
Gavreto is the first and only precision medicine approved in the EU for first-line treatment of people with RET fusion-positive advanced NSCLC
Premas Biotech is the developer of the technology for the Covid-19 vaccine and a shareholder in Oravax Medical
Achondroplasia is a genetic condition that causes severely short stature and disproportionate growth
The Ahmedabad based hospital in association with Sankalp India Foundation had established the BMT unit in 2017
Nelarabine is in a class of medications called antimetabolites
Six-months follow-up of prevention trial showed 83% reduced risk of symptomatic Covid-19, with no severe disease or deaths
Viyash has ten manufacturing facilities in India with a combined capacity of 2000 KL as well as one formulation facility in the US, and is now one of India’s leading mid-tier integrated API and formulation players
Two out of three people under the age of 40 are at risk of prediabetes
This test is inexpensive and results are available immediately as compared to the genetic test
Natco Pharma has reported consolidated financial results for the period ended September 30, 2021
Subscribe To Our Newsletter & Stay Updated
